Back
Biodexa Pharmaceuticals PLC Quote, Financials, Valuation and Earnings
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
3.55
Seasonality Move:
-24.92%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Biodexa Pharmaceuticals PLC Price Quote
$3.55
-0.07 (-26.95%)
(Updated: November 16, 2024 at 5:09 AM ET)
Biodexa Pharmaceuticals PLC Key Stats
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Day range:
$3.51 - $4.80
52-week range:
$3.51 - $220.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.26
P/B ratio:
0.19%
Volume:
64.3K
Avg. volume:
329.5K
1-year change:
-94.35%
Market cap:
$2.1M
Revenue:
$474.1K
EPS:
$-74.6
How Much Does Biodexa Pharmaceuticals PLC Make?
Data Unavailable
Is Biodexa Pharmaceuticals PLC Growing As A Company?
Data Unavailable
Biodexa Pharmaceuticals PLC Stock Price Performance
-
Did Biodexa Pharmaceuticals PLC Stock Go Up Last Month?
Biodexa Pharmaceuticals PLC share price went down by -27.74% last month -
Did BDRX's Share Price Rise Over The Last Year?
BDRX share price fell by -94.35% over the past 1 year
What Is Biodexa Pharmaceuticals PLC 52-Week High & Low?
-
What Is Biodexa Pharmaceuticals PLC’s 52-Week High Share Price?
Biodexa Pharmaceuticals PLC has traded as high as $220.25 over the past 52 weeks -
What Is Biodexa Pharmaceuticals PLC’s 52-Week Low Share Price?
Biodexa Pharmaceuticals PLC has traded as low as $3.51 over the past 52 weeks
Biodexa Pharmaceuticals PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Biodexa Pharmaceuticals PLC?
-
How Much Debt Does Biodexa Pharmaceuticals PLC Have?
Total long term debt quarterly is $0 -
How Much Cash Does Biodexa Pharmaceuticals PLC Have?
Cash and short term investments quarterly total is $6.4M -
What Is Biodexa Pharmaceuticals PLC’s Book Value Per Share?
Book value per share is 30.44
Is Biodexa Pharmaceuticals PLC Cash Flow Positive?
-
What Is BDRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.7M -
What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.8M -
What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.3M
Biodexa Pharmaceuticals PLC Return On Invested Capital
Data Unavailable
Biodexa Pharmaceuticals PLC Earnings Date & Stock Price
-
What Is Biodexa Pharmaceuticals PLC's Stock Price Today?
A single share of BDRX can be purchased today for 3.62 -
What Is Biodexa Pharmaceuticals PLC’s Stock Symbol?
Biodexa Pharmaceuticals PLC trades on the nasdaq under the ticker symbol: BDRX -
When Is Biodexa Pharmaceuticals PLC’s Next Earnings Date?
The next quarterly earnings date for Biodexa Pharmaceuticals PLC is scheduled on April 18, 2025 -
When Is BDRX's next ex-dividend date?
Biodexa Pharmaceuticals PLC's next ex-dividend date is November 18, 2024 -
How To Buy Biodexa Pharmaceuticals PLC Stock?
You can buy Biodexa Pharmaceuticals PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Biodexa Pharmaceuticals PLC Competitors
-
Who Are Biodexa Pharmaceuticals PLC's Competitors?
Below is a list of companies who compete with Biodexa Pharmaceuticals PLC or are related in some way:
Biodexa Pharmaceuticals PLC Dividend Yield
-
What Is BDRX Dividend Yield?
Biodexa Pharmaceuticals PLC’s dividend yield currently is 0% -
What Is Biodexa Pharmaceuticals PLC’s Payout Ratio?
Biodexa Pharmaceuticals PLC’s payout ratio is 0% -
When Did Biodexa Pharmaceuticals PLC Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is Biodexa Pharmaceuticals PLC’s Dividend Per Share?
Biodexa Pharmaceuticals PLC pays a dividend of $0.00 per share
Biodexa Pharmaceuticals PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 8.02 |
| Upside from Last Price: | 121.41% |